Exelixis (EXEL) Long-Term Investments (2010 - 2026)

Exelixis' (EXEL) quarterly Long-Term Investments came in at $649.1 million in Q2 2026, up 4.8% year-on-year from $619.4 million in Q2 2025, and up 7.54% quarter-over-quarter from $603.6 million in Q1 2026.

Exelixis (EXEL) Long-Term Investments (2010 - 2026) Analysis & Trends

Exelixis' Long-Term Investments history runs 17 years deep, the most recent figure standing at $649.1 million for Q2 2026.

  • On a quarterly basis, Long-Term Investments rose 4.8% year-over-year to $649.1 million in Q2 2026; TTM through Apr 2026 was $649.1 million, a 4.8% increase from a year earlier, with the FY2026 full-year figure at $603.6 million, down 5.29% from the prior year.
  • Long-Term Investments rose to $649.1 million in Q2 2026 per EXEL's latest filing, from $603.6 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $838.6 million in Q2 2023 and bottomed at $404.5 million in Q2 2022.
  • The 5-year median for Long-Term Investments is $619.4 million (2025), against an average of $625.3 million.
  • Across the five-year window, Long-Term Investments soared 103.91% in 2022 and plunged 48.45% in 2024, its largest moves.
  • Year by year, Long-Term Investments stood at $756.7 million in 2022, then slipped by 3.7% to $728.7 million in 2023, then dropped by 28.17% to $523.4 million in 2024, then increased by 10.48% to $578.3 million in 2025, then climbed by 12.25% to $649.1 million in 2026.
  • Per Business Quant, the three latest EXEL Long-Term Investments figures stand at $649.1 million (Q2 2026), $603.6 million (Q1 2026), and $578.3 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 505,194.89
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 9.79 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn 649.14 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 649.14 Mn
Jan 2, 2026 603.60 Mn
Oct 3, 2025 578.29 Mn
Jul 4, 2025 594.65 Mn
Apr 4, 2025 619.44 Mn
Jan 3, 2025 637.29 Mn
Sep 27, 2024 523.42 Mn
Jun 28, 2024 432.31 Mn
Mar 29, 2024 629.56 Mn
Dec 29, 2023 728.72 Mn
Sep 29, 2023 811.68 Mn
Jun 30, 2023 838.62 Mn
Mar 31, 2023 806.62 Mn
Dec 30, 2022 756.73 Mn
Sep 30, 2022 551.74 Mn
Jul 1, 2022 463.89 Mn
Apr 1, 2022 404.54 Mn
Dec 31, 2021 371.11 Mn
Oct 1, 2021 362.22 Mn
Jul 2, 2021 345.61 Mn